SCHEMBL7015129

SCHEMBL7015129

Cc1ccc(-c2ccccc2-c2n[nH]c(=O)n2C)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.47
HSD17B10 Q99714 1/20 0.47
ALDH1A1 P00352 5/20 0.45
PKM P14618 2/20 0.45
KDM4E B2RXH2 3/20 0.45
GAA P10253 2/20 0.45
NOTUM Q6P988 1/20 0.44
LTK P29376 2/20 0.43
ALK Q9UM73 2/20 0.43
DYRK1B Q9Y463 2/20 0.43
RET P07949 1/20 0.43
MET P08581 1/20 0.43
GRK5 P34947 1/20 0.43
CDK8 P49336 1/20 0.43
RPS6KA3 P51812 1/20 0.43
MST1R Q04912 1/20 0.43
TYRO3 Q06418 1/20 0.43
DYRK1A Q13627 1/20 0.43
LRRK2 Q5S007 1/20 0.43
CLK4 Q9HAZ1 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9485160 0.84 LRRK2 (0.42) ALDH1A1KDM4EGAANOTUMLTK
SCHEMBL2896019 0.84 HSD17B10 (0.65) LMNAHSD17B10ALDH1A1KDM4EGAA
SCHEMBL9120422 0.78 HSD11B1 (0.58) LMNAALDH1A1PKMKDM4EGAA
SCHEMBL3520851 0.77 PDE3B (0.47) LMNAHSD17B10ALDH1A1KDM4ELTK
SCHEMBL24352880 0.75 ALDH1A1 (0.44) LMNAALDH1A1PKMKDM4ENOTUM
SCHEMBL7017759 0.75 CYP1A2 (0.43) LMNAALDH1A1LTKALKDYRK1B
SCHEMBL7013941 0.74 NOTUM (0.71) NOTUM
SCHEMBL24352879 0.74 ALDH1A1 (0.43) ALDH1A1PKMKDM4EGAANOTUM
SCHEMBL8036362 0.73 LMNA (0.50) LMNAALDH1A1PKMKDM4EHPGD
SCHEMBL24352210 0.72 ALDH1A1 (0.41) LMNAHSD17B10ALDH1A1PKMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0520423-B1 Heterocyclic compounds, their production and use as angiotensin II antagonists TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-05-14 EP disclosed
US-6100252-A SPECIFIED COMPOUNDS INCLUDING METHYL 2-BUTYL-1-((2'-(2-OXO-3H-1,2,3,5-OXATHIADIAZOL-4-YL)BIPHENYL) METHYL)-BENZIMIDAZOLE-7-CARBOXYLATE; USE TO TREAT CIRCULATORY DISEASES SUCH AS HYPERTENSIVE DISEASES AND HEART DISEASES TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2000-08-08 US disclosed
US-5883111-A STRONG AND LONG-LASTING ACTION BY ORAL ADMINISTRATION; HYPOTENSIVE AGENTS; CARDIOTONIC AGENTS; ALZHEIMER'S DISEASE; TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-03-16 US disclosed
US-5736555-A HYPOTENSIVE AGENTS; FDA ORANGE BOOK LISTED PATENT FOR AZILSARTAN MEDOXOMIL TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-04-07 US disclosed
US-5583141-A ADMINISTERING AS THERAPEUTIC AGENTS OF CIRCULATORY DISEASES; AZILSARTAN; ANGIOTENSIN II ANTAGONISTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-12-10 US disclosed
EP-0520423-A2 Heterocyclic compounds, their production and use as angiotensin II antagonists TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-12-30 EP disclosed